{"id":128944,"date":"2023-01-09T16:48:38","date_gmt":"2023-01-09T16:48:38","guid":{"rendered":"https:\/\/ccs.ca\/?post_type=guideline&p=128944"},"modified":"2023-04-12T05:00:02","modified_gmt":"2023-04-12T05:00:02","slug":"chapter-10-gaps-in-evidence-and-ongoing-trials","status":"publish","type":"guideline","link":"https:\/\/ccs.ca\/guideline\/2017-heart-failure-management-of-hf\/chapter-10-gaps-in-evidence-and-ongoing-trials\/","title":{"rendered":"10. Gaps in Evidence and Ongoing Trials"},"content":{"rendered":"\n
The CCS HF guidelines panel identified several gaps in evidence that, when filled, will aid in the diagnosis, prognosis, treatment, or organization of care for patients with HF. These are not exhaustive and many research avenues should be pursued by the Canadian and global research community.<\/p>\n\n\n\n